Bernhard Opitz

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

Metastasis: from dissemination to organ-specific colonization

Pancreatic cancer

Contribution of platelets to tumour metastasis

Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma

Anti-cancer properties of low-molecular-weight heparin: Preclinical evidence

Therapy for Cancer-Related Thromboembolism

Advanced pancreatic carcinoma: current treatment and future challenges

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

Lack of Evidence to Support Thromboprophylaxis in Hospitalized Medical Patients with Cancer

Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive

Prevention of VTE in Nonsurgical Patients

Amelioration of fetal alcohol-related neurodevelopmental disorders in rats

Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer

Dendritic Anomalies in Disorders Associated with Mental Retardation

Risk assessment for cancer-associated thrombosis: What is the best approach?

Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United States

Parenteral anticoagulation in patients with cancer who have no therapeutic or prophylactic indication for anticoagulation

Thrombosis and cancer

Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20)

Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx

Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy

Pancreatic cancer

Management of glioblastoma: State of the art and future directions

Low-Molecular-Weight Heparin Versus Placebo for the Prevention of Venous Thromboembolism in Metastatic Breast Cancer or Stage III/IV Lung Cancer

Metastatic Pancreatic Cancer 2008: Is the Glass Less Empty?

Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer

Lost in translation: animal models and clinical trials in cancer treatment.

High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis

Anticoagulation for people with cancer and central venous catheters

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)

Differential effects of communal rearing and preweaning handling on open-field behavior and hot-plate latencies in mice

Effects of prenatal ethanol exposure and early experience on home-cage and open-field activity in mice

A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): Results of the CONKO 004 trial

A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): Results of the CONKO 004 trial

6513 Successful prevention of symptomatic thromboembolic events by the low molecular weight heparin enoxaparin in patients with advanced pancreatic cancer – results of the CONKO 004 trial

A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy (PROSPECT - CONKO 004)

Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

A prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy: Final results of the CONKO-004 trial.

A prospective, randomized trial of chemotherapy with or without the low molecular weight heparin (LMWH) enoxaparin in patients (pts) with advanced pancreatic cancer (APC): Results of the CONKO 004 trial